CytomX Therapeutics (CTMX) Capital Expenditures Growth (1y) (2015 - 2025)
CytomX Therapeutics (CTMX) Capital Expenditures Growth (1y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 38.18% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -27.93% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | CytomX Therapeutics | 590.32 Mn | 243.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 151.25% |
| Sep 30, 2025 | -768.42% |
| Jun 30, 2025 | -71.88% |
| Mar 31, 2025 | 3.48% |
| Dec 31, 2024 | 116.03% |
| Sep 30, 2024 | 111.11% |
| Jun 30, 2024 | -81.43% |
| Mar 31, 2024 | 139.58% |
| Dec 31, 2023 | -374.18% |
| Sep 30, 2023 | -97.80% |
| Jun 30, 2023 | 25.49% |
| Mar 31, 2023 | -93.48% |
| Dec 31, 2022 | -25.71% |
| Sep 30, 2022 | 52.99% |
| Jun 30, 2022 | 261.40% |
| Mar 31, 2022 | -25.05% |
| Dec 31, 2021 | 114.06% |
| Sep 30, 2021 | -65.55% |
| Jun 30, 2021 | 208.11% |
| Mar 31, 2021 | -6.39% |